Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$533K Sell
5,002
-1,668
-25% -$202K 0.01% 920
2026
Q1
$1.09M Buy
6,670
+2,669
+67% +$410K 0.02% 631
2025
Q4
$696K Buy
4,001
+2,512
+169% +$458K 0.01% 749
2025
Q3
$214K Buy
+1,489
New +$182K ﹤0.01% 1095

Other funds holding INSM

Ethic Inc's INSM Position: Q2 2026 in Review

Ethic Inc reduced its Insmed (INSM) stake by 25% in Q2 2026, selling an estimated $202K and leaving 5,002 shares worth $533K. The position accounts for 0.01% of the portfolio, ranked #920.

Ethic Inc first reported a position in INSM in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.09M in Q1 2026. 161 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Ethic Inc held 5,002 shares of Insmed worth $533K as of Q2 2026.
  • Ethic Inc sold 1,668 Insmed shares in Q2 2026, an estimated $202K.
  • Insmed made up 0.01% of Ethic Inc's portfolio in Q2 2026, its #920 holding.
  • Ethic Inc first reported a position in Insmed in Q3 2025 and has held it in 4 quarters since.
  • Ethic Inc's Insmed position peaked at $1.09M in Q1 2026.
  • 161 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.